Rodgers, James D.,Combs, Andrew,Maduskuie, Thomas,Sparks, Richard
申请号：
NZ71245314
公开号：
NZ712453A
申请日:
2014.03.14
申请国别(地区):
NZ
年份:
2020
代理人:
摘要：
The present invention relates to tricyclic heterocycles of Formula (I) or pharmaceutically acceptable salts thereof, which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer, viral infections, autoimmune diseases and inflammatory diseases.
